The Funding category provides information on financial resources and opportunities available for the development of new therapies. This includes grants, venture capital, public and private funding programs, and other financial support mechanisms that can help researchers, startups, and established companies advance their therapeutic projects. The goal is to connect innovators with the necessary financial resources to support their research, development, and commercialization efforts, help to navigate the funding landscape and prepare successful applications. This category also offers guidance on how to apply socialy responsible licensing. Socially responsible licensing means that account must be taken of the effective availability of the products or services to be developed based on the licensed knowledge.
Useful links subsidies
-
Biotech Booster is a national program funded by the Dutch National Growth Fund that supports the commercialization of biotechnology findings in The Netherlands. The Biotech Booster program offers mentorship, financial support and networking opportunities, to guide founders from the idea stage to developing an investable and commercial proposition.
-
PharmaNL is a National Growth Fund initiative focusing on enhancing pharmaceutical education/human capital and creating a shared infrastructure for the development, scaling, and production of innovative medicines in the Netherlands. You can apply for funding via subsidy rounds by ZonMw.
Organizations
-
ZonMw (The Netherlands Organisation for Health Research and Development) provides public funding on various subjects like rational pharmacotherapy research and implementation (GGG), shared infrastructure and human capital (PharmaNL), animal free modeling. Please see the funding opportunities at the ZonMw website.
-
Health~Holland has funding available for public-private partnerships through instruments such as the MKB call: Funding Opportunities | Health~Holland
-
The Netherlands Enterprise Ageny (RVO) has financial support options for start-ups: Subsidy and Funding Guide. RVO has an address for advice. You can ask questions to the team MKB-Financiering (mkbfinanciering@rvo.nl) or call 088-0428600. This team can advice you on which rulings are suitable for your situation.
-
InvestNL has funding available for parties that have private cofinancing available. Invest-NL provides up to 50% of the venture capital, with an investment from Invest-NL between € 5 million - € 50 million, in principle. The investment needs to contribute to affordable and accessible healthcare, to the innovative capacity of the Netherlands. Please see the quickscan whether their financial instruments are applicable for your innovation.
-
Dutch regional development agencies (RDAs) (in Dutch: Regionale Ontwikkelings Maatschappijen (ROMs))
RDAs help entrepreneurs with innovation, investments and internationalization. They operate in a regional setting and invest in innovative, fast-growing companies from their own funds and funds under thier management. They do this by providing subordinated loans and/or share capital.
Please look for the RDA in your region: ROM’s – De regionale ontwikkelingsmaatschappijen in Nederland